Cefiderocol, a novel siderophore cephalosporin, may be successful in patients with persistently bacteremic nosocomial native aortic valve endocarditis.
You may also like
Clinical CMR: one-year case mix, outcomes and stress-testing accuracy from a regional tertiary centre
- October 19, 2019
Cardiac magnetic resonance (CMR)Read more
The effect of ageing on the frontal QRS-T angle on the 12-lead ECG
- October 18, 2019
The frontal QRS-T angle (QTA) isRead more